Skip to main content
SpringerLink
Log in

Inotropic Therapy in Acute Circulatory Failure

  • Chapter
Update 1987

Part of the book series: Update in Intensive Care and Emergency Medicine ((UICM,volume 3))

Abstract

Various definitions of “acute circulatory failure” (ACF) can be given according to the criteria considered as most meaningful (cardiac output, systemic pressures or others). In this article, we will define ACF in terms of inappropriate peripheral (tissular or even better, cellular) oxygen supply. This definition has the advantage to clearly specify that the therapy has to aim to improvement of oxygen tissular delivery, i.e. to optimization of arterial O2 content and O2 transport. Optimization of arterial O2 content is not the subject of this discussion, but O2 transport is the basis of our topic. O2 transport does not only depend on cardiac output: considerations about microcirculation and rheology would be here of primary importance but, once again, fall outside our topic. In treating ACF we have to take into account the quality of tissular perfusion.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Colucci WS, Wright RF, Braunwald E (1986) New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments (First of two parts). N Engl J Med 314:290–299

    Article  PubMed  CAS  Google Scholar 

  2. Colucci WS, Wright RF, Braunwald E (1986) New postive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments (Second of two parts). N Engl J Med 314:349–358

    Article  PubMed  CAS  Google Scholar 

  3. Mueller HS (1985) Inotropic agents in the treatment of cardiogenic shock. World J Surg 9:3–10

    Article  PubMed  CAS  Google Scholar 

  4. Handler CE (1985) Cardiogenic shock. Postgraduate Med J 61:705–712

    Article  CAS  Google Scholar 

  5. Baumann G (1986) Acute effects of dopexamine hydrochloride, in comparison to dobutamine and nitroprussiate in patients with chronic cardiac failure. X World congress of cardiology, Washington DC, Abstract book, 1077

    Google Scholar 

  6. Foulds RA, Magrini F, Zanchetti A (1986) The renovascular effects of dopexamine hydrochloride, a dopaminergic and β2 adrenergic agonist. X World congress of cardiology, Washington DC, Abstract book, 1151

    Google Scholar 

  7. Colardyn F (1986) Acute and long-term haemodynamic effects of dopexamine hydrochloride in patients with chronic cardiac failure. X World congress of cardiology, Washington DC, Abstract book, 1980

    Google Scholar 

  8. Mancini D, LeJemtel T, Sonnenblick E (1985) Intravenous use of amrinone for the treatment of the failing heart. Am J Cardiol 56:8B–15B

    Article  PubMed  CAS  Google Scholar 

  9. Sonnenblick EH, Grose R, Strain J, Zelcer AA, LeJemtel T (1986) Effects of milrinone on left ventricular performance and myocardial contractility in patients with severe heart failure. Circulation 73:III-162–167

    CAS  Google Scholar 

  10. Uretsky BF, Valdes AM, Reddy PS (1986) Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure : hemodynamic effects and clinical efficacy of MDL 17,043. Circulation 73:III-219–229

    CAS  Google Scholar 

  11. Petein M, Levine TB, Cohn JN (1984) Hemodynamic effects of a new inotropic agent, MDL 19,205, in patients with chronic heart failure. J Am Coll Cardiol 2:364–370

    Article  Google Scholar 

  12. Renard M, Liebens I, Walter M, Bernard R (1986) Acute and long-term response to oral pimobendan (UD-CG115) in patients with congestive heart failure. X World congress of cardiology, Washington DC, Abstract book, 1177

    Google Scholar 

  13. Jafri SM, Burlew BS, Goldberg AD, Rogers A, Goldstein S (1986) Hemodynamic effects of a new type III phosphodiesterase inhibitor (CI-914) for congestive heart failure. Am J Cardiol 57:254–259

    Article  PubMed  CAS  Google Scholar 

  14. Daly PA, Chatterjee K, Viquerat CE, Parmley WW, Curran D, Scheinbaum M, Anderson S (1985) RO13-6438, a new inotrope-vasodilator: systemic and coronary hemodynamic effects in congestive heart failure. Am J Cardiol 55:1539–1544

    Article  PubMed  CAS  Google Scholar 

  15. Salzmann R, Scholtysik G, Clark B, Berthold D (1986) Cardiovascular actions of DPI 201-106, a novel cardiotonic agent. J Cardiovasc Pharmacol 8:1035–1043

    Article  PubMed  CAS  Google Scholar 

  16. Domb M, Van der Linden P, Azimi G, Motte S, de Boelpaepe C, Vincent JL (1986) Treatment of septic shock with amrinone: an experimental study. Crit Care Med 14:347

    Article  Google Scholar 

  17. Vincent JL, Van Reeth O, Van Bogaert E, Berré J, Kahn R (1986) Use of the new inotropic agent ARL-115 BS to treat severe myocardial depression in septic shock. Crit Care Med 14:661–662

    Article  Google Scholar 

  18. Massari FM, Foresti A, Valentini R, Bertoni T, De Martini M, Lotto A (1986) Clinical and hemodynamic evaluation of amrinone in acute myocardial infarction complicated by cardiogenic shock. X World congress of cardiology, Washington DC, Abstract book, 2524

    Google Scholar 

  19. Taylor SH, Verma SP, Hussain M, Reynolds G, Jackson NC, Hafizullah M, Richmond A, Silke B (1985) Intravenous amrinone in left ventricular failure complicated by acute myocardial infarction. Am J Cardiol 56:29B–32B

    Article  PubMed  CAS  Google Scholar 

  20. Goenen M. Pedemonte O, Baele P, Col J (1985) Amrinone in the management of low cardiac output after open heart surgery. Am J Cardiol 56:33B–38B

    Article  PubMed  CAS  Google Scholar 

  21. Installé E, Gonzalez M, Jacquemart JL, Guillaume JE, Anton E, Tremouroux J (1986) Efficacy of enoximone (MDL 17043) in refractory post-cardiac surgery low output syndrome. Acta Pharmacol Toxicol 59, Suppl V:182

    Google Scholar 

  22. Installé E, Gonzalez M, Jacquemart JL, Collard P, Roulette F, Pourbaix S, Tremouroux J. Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine, and ni-troprusside in patients with severe congestive heart failure. Am J Cardiol (in press)

    Google Scholar 

  23. Monrad ES, Baim DS, Smith HS, Lanoue AS (1986) Milrinone, dobutamine, and nitroprus-side: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure. Circulation 73:III-168–174

    Article  CAS  Google Scholar 

  24. Likoff MJ, Ulrich S, Hakki A, Iskandrian AS (1986) Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17,043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathy. Am J Cardiol 57:1328–1334

    Article  PubMed  CAS  Google Scholar 

  25. Uretsky BF, Generalovich T, Verbalis JG, Valdes AM, Reddy PS (1986) Comparative hemodynamic and hormonal response of enoximone and dobutamine in severe congestive heart failure. Am J Cardiol 58:110–116

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. E. Installé
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Intensive Care, Erasme Hospital, Free University of Brussels, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean Louis Vincent (Assistant-Director) (Assistant-Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Installé, E. (1987). Inotropic Therapy in Acute Circulatory Failure. In: Vincent, J.L. (eds) Update 1987. Update in Intensive Care and Emergency Medicine, vol 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83042-6_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83042-6_35

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-17576-6

  • Online ISBN: 978-3-642-83042-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation